Osteoporosis: Romosozumab

<p>Biologic agents targeting key proteins involved in bone homeostasis are revolutionizing the management of osteoporosis. New clinical data support the use…
nature.com

Romosozumab rapidly and dramatically reduces vertebral fractures compared with placebo in FRAME, and bone-enhancing effects continue after patients…
medscape.com
MADRID – Investigational bone-building drug looks promising, but safety concerns emerge.
mdedge.com

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis (The ARCH Trial)

nejm.org

ARCH (Active-Controlled Fracture Study in Postmenopausal Women with Osteoporosis at High Risk)

Romosozumab — Promising or Practice Changing?

Editorial from The New England Journal of Medicine — Romosozumab — Promising or Practice Changing?
nejm.org

A complete response letter is not an unexpected heartbreak for Evenity after Phase 3 data showed some worrying safety signals.
biopharmadive.com